Cargando…

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

Detalles Bibliográficos
Autores principales:	Tikkinen, Kari A O, Dahm, Philipp, Lytvyn, Lyubov, Heen, Anja F, Vernooij, Robin W M, Siemieniuk, Reed A C, Wheeler, Russell, Vaughan, Bill, Fobuzi, Awah Cletus, Blanker, Marco H, Junod, Noelle, Sommer, Johanna, Stirnemann, Jérôme, Yoshimura, Manabu, Auer, Reto, MacDonald, Helen, Guyatt, Gordon, Vandvik, Per Olav, Agoritsas, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2018
Materias:	Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283372/ https://www.ncbi.nlm.nih.gov/pubmed/30185545 http://dx.doi.org/10.1136/bmj.k3581

Ejemplares similares

Patient values and preferences on valve replacement for aortic stenosis: a systematic review
por: Heen, Anja Fog, et al.
Publicado: (2021)

Establishing thresholds for important benefits considering the harms of screening interventions
por: Helsingen, Lise Mørkved, et al.
Publicado: (2020)

Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review
por: Lytvyn, Lyubov, et al.
Publicado: (2016)

Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials
por: Sadeghirad, Behnam, et al.
Publicado: (2017)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
por: Ilic, Dragan, et al.
Publicado: (2018)

Low intensity pulsed ultrasound for bone healing: systematic review of randomized controlled trials
por: Schandelmaier, Stefan, et al.
Publicado: (2017)

Decision aids linked to evidence summaries and clinical practice guidelines: results from user-testing in clinical encounters
por: Heen, Anja Fog, et al.
Publicado: (2021)

Decision aids that really promote shared decision making: the pace quickens
por: Agoritsas, Thomas, et al.
Publicado: (2015)

Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review
por: Zeng, Linan, et al.
Publicado: (2021)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Trustworthy guidelines – excellent; customized care tools – even better
por: Elwyn, Glyn, et al.
Publicado: (2015)

Minimal important differences for improvement in shoulder condition patient-reported outcomes: a systematic review to inform a BMJ Rapid Recommendation
por: Hao, Qiukui, et al.
Publicado: (2019)

Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline
por: Siemieniuk, Reed A C, et al.
Publicado: (2017)

General practitioners’ reflections on using PSA for diagnosis of prostate cancer. A qualitative study
por: Thorsen, Olav, et al.
Publicado: (2022)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis
por: Riikonen, Jarno M., et al.
Publicado: (2019)

Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis
por: Jodal, Henriette C, et al.
Publicado: (2019)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)

Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations
por: Devji, Tahira, et al.
Publicado: (2017)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Values and preferences of women living with HIV who are pregnant, postpartum or considering pregnancy on choice of antiretroviral therapy during pregnancy
por: Lytvyn, Lyubov, et al.
Publicado: (2017)

Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature
por: Abrate, Alberto, et al.
Publicado: (2014)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
por: Chavan, Sushant V., et al.
Publicado: (2014)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
por: Flores-Fraile, María-Carmen, et al.
Publicado: (2020)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

WHO Living Guidelines on antivirals for COVID-19 are evidence-based
por: Owen, Andrew, et al.
Publicado: (2023)

Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men
por: Coric, Jozo, et al.
Publicado: (2015)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Incidence of Histological Prostatitis and Its Correlation with PSA Density
por: Piovesan, Affonso Celso, et al.
Publicado: (2009)

Usefulness of Total PSA Value in Prostate Diseases Diagnosis
por: Prcic, Alden, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_omu7i1qee3n39pa4qlrr5ak59r